EhranNas QIAGENNetherlands

EhranNas
Experienced Senior Regional Marketing Manager with 15 years in the In Vitro Diagnostics (IVD) and Molecular Diagnostics industry, specializing in Genomics and Next-Generation Sequencing (NGS). Proven track record in driving business growth through strategic marketing initiatives, market assessments, and developing commercial tactics. Skilled in precision medicine and oncology clinical research, with a focus on fostering scientific collaborations and KOL networks. Adept at leading complex interdisciplinary projects, ensuring successful implementation of strategic plans. Strong expertise in commercialization of NGS and PCR instruments, associated chemistries and kits, and bioinformatics. My expertise in infectious diseases, oncology, and human genetics complements my versatile skill set in business strategy and sales management.

Monday 08 June 2026

Time Session
13:15
14:00
QIAGEN GmbH Industry Symposium: Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
γδ T cells are increasingly recognized for their role in anti-tumor immunity and Vδ1 T cells have been reported as the predominant γδ subset infiltrating the microenvironment of several cancers. However, their contribution in this setting remains unclear and flow cytometry alone has provided limited insights into their functionality. In this symposium, Prof. Domenico Mavilio (IRCCS Humanitas Research Hospital, Milan, Italy) will present how transcriptome and repertoire profiling at bulk and single cell resolution can clarify γδ T-cell states and provide clues on tumor escape mechanisms. By linking transcriptional state, repertoire, and therapeutic response, this work underscores the potent antitumor role of Vδ1 T cells in endometrial cancer and highlights their potential as therapeutic targets to enhance anti–PD-1 checkpoint inhibitor strategies in the future.
Room F9+10